Moneycontrol Be a Pro
Get App
Last Updated : Dec 27, 2018 12:11 PM IST | Source: Moneycontrol.com

Buy Abbott India, target Rs 8,450: Dharmesh Shah

We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities.

Moneycontrol Contributor @moneycontrolcom
Abbott-Piramal acquisition | Year: May 2010 | Deal size: USD 3.7 billion Objective: To increase presence in the Indian branded generics space. Result: Expensive deal with Abbott paying 8.8 times of Piramal sales. While the acquisition strengthened Abbott’s market position and product portfolio in India, sales growth are highly unlikely to reach Abbott’s USD 2.5 billion revenue target for 2020. (Image Reuters)
Abbott-Piramal acquisition | Year: May 2010 | Deal size: USD 3.7 billion Objective: To increase presence in the Indian branded generics space. Result: Expensive deal with Abbott paying 8.8 times of Piramal sales. While the acquisition strengthened Abbott’s market position and product portfolio in India, sales growth are highly unlikely to reach Abbott’s USD 2.5 billion revenue target for 2020. (Image Reuters)
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dharmesh Shah

Abbott India is in secular uptrend as it continues to form higher peak and higher trough in the monthly chart and is seen trading in a rising channel highlighting sustained buying demand at elevated levels. The last three month corrections has seen the stock testing the lower band of the channel thus providing fresh entry opportunity to ride the next up move in the stock.

The share price of Abbott India has registered a breakout above multiyear highs around Rs 6170 levels during middle of previous year. The stock post the breakout has rallied and hit an all time high of Rs 8820 during September 2018. The last three months sideways corrective consolidation has helped the stock work off the overbought condition developed after the previous sharp rally. The stock is currently placed at the major support area of Rs 6900-7100 being the confluence of:

Close

- The lower band of the rising channel placed since CY’17

- 50 percent retracement of the previous up move Rs 5430-Rs 8820 placed at Rs 7130 levels.

The stock has already taken four months to retraced just 50 percent of the previous five months up move (Rs 5430 to Rs 8820). A slower retracement suggests corrective nature of current decline and positive price structure

We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term as it is the 80 percent retracement of the entire previous decline (Rs 8820-6900) placed around Rs 8450 levels.

Disclaimer: The author is Head Technical at ICICI Securities. The views and investment tips expressed by investment experts/broking houses/rating agencies on Moneycontrol are their own, and not that of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Dec 27, 2018 12:11 pm
Loading...
Sections
Follow us on
Available On
Trusted By 1cr Families
Medlife Health Comes Home